CARL HANNAH: Open Payments
NPI 1700848363 · CHRISTIANSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,203 in 62 payments from 17 companies in 2025. Trend: 2023 $2,092 · 2024 $1,771 · 2025 $1,203
Food & beverage: $1,203
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $205 |
| AstraZeneca Pharmaceuticals LP | 11 | $202 |
| PFIZER INC. | 10 | $169 |
| Lilly USA, LLC | 5 | $108 |
| Amgen Inc. | 6 | $100 |
| Novo Nordisk Inc | 4 | $89 |
| Astellas Pharma US Inc | 2 | $45 |
| Boston Scientific Corporation | 1 | $40 |
| Inspire Medical Systems, Inc. | 1 | $40 |
| GlaxoSmithKline, LLC. | 2 | $34 |
Products named: CAPLYTA, NURTEC ODT, MOUNJARO, BREZTRI, AIRSUPRA, EVENITY, Ozempic, Veozah.
Industry payments across VA — which companies pay providers there.
